Comparable stake leader
ARMISTICE CAPITAL, LLC
SEC ownership of Enveric Biosciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000890821.
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
38/42
Latest evidence
30 Jun 2026
- Public ticker
- ENVB on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
ARMISTICE CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
38 of 42
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
ARMISTICE CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000890821
- Issuer location
- Cambridge, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Enveric Biosciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
38/42
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
4 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-8 of 42 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 10%.
38 of 42 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
10%
INTRACOASTAL CAPITAL, LLC
5%
Orca Capital AG
4.9%
Ayrton Capital LLC
2.9%
AdvisorShares Trust
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 42 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
10%
|
$550,925
405,092 shares
|
$0 | 30 Jun 2026 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$278,572
71,246 shares
|
+$155,982 | 27 Jan 2026 |
| Orca Capital AG |
13D/G
|
4.9%
|
$32,016
97,019 shares
|
-$22,984 | 31 Jan 2025 |
| Ayrton Capital LLC |
13D/G
|
2.9%
|
$151,157
111,145 shares
|
-$744,355 | 30 Jun 2026 |
| AdvisorShares Trust |
13D/G
|
1.7%
|
$5,601
16,974 shares
|
-$61,613 | 31 Dec 2025 |
| Lind Global Fund III LP |
13D/G
EASTON JEFF
|
1.4%
|
$70,538
51,866 shares
|
-$148,738 | 30 Jun 2026 |
| Joseph Edward Tucker |
3/4/5
Chief Executive Officer, Director
|
7.3%
|
$526,723
271,479 shares
|
— | 01 Jun 2026 |
| Kevin Michael Coveney |
3/4/5
Chief Financial Officer
|
4.9%
|
$350,683
180,746 shares
|
— | 01 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to Enveric Biosciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Joseph Edward Tucker
Net 12M change
$0
Latest report
01 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Joseph Edward Tucker | Chief Executive Officer, Director | $526,723 | Mixed | 01 Jun 2026 | ||
| Kevin Michael Coveney | Chief Financial Officer | $350,683 | Mixed | 01 Jun 2026 | ||
| Peter J. Facchini | Chief Innovation Officer | $53,850 | Mixed | 01 Jun 2026 | ||
| Frank Pasqualone | Director | $51,265 | Mixed | 01 Jun 2026 | ||
| Marcus Schabacker | Director | $51,256 | Mixed | 01 Jun 2026 | ||
| George A. Kegler | Director | $51,256 | Mixed | 01 Jun 2026 | ||
| Michael D. Webb | Director | $51,252 | Mixed | 01 Jun 2026 | ||
| Sheila DeWitt | Director | $51,038 | Mixed | 01 Jun 2026 | ||
| Avani Kanubaddi | President and COO | Mixed | 25 Jan 2023 | |||
| Carter Julian Ward | Chief Financial Officer | Mixed | 19 Jan 2022 | |||
| Thompson Bradley George | Director | Mixed | 16 Sep 2021 | |||
| Robert Dickey IV | Chief Financial Officer | Mixed | 09 Sep 2022 | |||
| Bevin O'Neil | Director | Mixed | 13 Jun 2022 | |||
| Jillian Marie Hagel | Vice President of Innovation | Mixed | 25 Jan 2023 |
Recent insider transactions for Enveric Biosciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Kevin Michael Coveney | ENVB | Common Stock | Award | 281.2% | 133,333 | 180,746 | 01 Jun 2026 | Direct | ||
| Joseph Edward Tucker | ENVB | Common Stock | Award | 285.9% | 201,124 | 271,479 | 01 Jun 2026 | Direct | ||
| Frank Pasqualone | ENVB | Common Stock | Award | 234.3% | 18,518 | 26,423 | 01 Jun 2026 | Direct | ||
| Michael D. Webb | ENVB | Common Stock | Award | 234.5% | 18,518 | 26,416 | 01 Jun 2026 | Direct | ||
| Marcus Schabacker | ENVB | Common Stock | Award | 234.4% | 18,518 | 26,418 | 01 Jun 2026 | Direct | ||
| George A. Kegler | ENVB | Common Stock | Award | 234.4% | 18,518 | 26,418 | 01 Jun 2026 | Direct | ||
| Sheila DeWitt | ENVB | Common Stock | Award | 237.8% | 18,518 | 26,306 | 01 Jun 2026 | Direct | ||
| Peter J. Facchini | ENVB | Common Stock | Award | 907.4% | 25,000 | 27,755 | 01 Jun 2026 | Direct | ||
| Sheila DeWitt | ENVB | Common Stock | Award | 4924.5% | 7,633 | 7,788 | 23 Dec 2025 | Direct | ||
| George A. Kegler | ENVB | Common Stock | Award | 2858.8% | 7,633 | 7,900 | 23 Dec 2025 | Direct | ||
| Frank Pasqualone | ENVB | Common Stock | Award | 2816.6% | 7,633 | 7,904 | 23 Dec 2025 | Direct | ||
| Marcus Schabacker | ENVB | Common Stock | Award | 2858.8% | 7,633 | 7,900 | 23 Dec 2025 | Direct | ||
| Joseph Edward Tucker | ENVB | Common Stock | Award | 599.4% | 60,296 | 70,355 | 23 Dec 2025 | Direct | ||
| Michael D. Webb | ENVB | Common Stock | Award | 2880.4% | 7,633 | 7,898 | 23 Dec 2025 | Direct | ||
| Kevin Michael Coveney | ENVB | Common Stock | Award | 557.1% | 40,198 | 47,413 | 23 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.